Family Planning Associates Medical Group INC
Family Planning Associates Medical Group INC was paid $12.60M by Medicaid between Jan 2018 and Dec 2024, across 52 billing codes. Its largest line is S0199, Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs — 27% of everything it billed.
BAKERSFIELD, CA 93301
Next to other Obstetrics & Gynecology Physician providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,772 | $1.31M | |
| 2019 | 13,963 | $1.25M | |
| 2020 | 14,126 | $1.80M | |
| 2021 | 16,287 | $1.97M | |
| 2022 | 17,322 | $2.06M | |
| 2023 | 20,617 | $2.24M | |
| 2024incomplete | 17,483 | $1.97M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 27% | 6,585 | 6,443 | $3.34M |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 19% | 2,255 | 2,192 | $2.44M |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 6.3% | 783 | 768 | $794K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 6.2% | 17,010 | 16,145 | $779K |
| 59840 | 4.7% | 3,783 | 1,864 | $590K | |
| J3490 | Unclassified drugs | 4.5% | 12,839 | 11,618 | $564K |
| 90651 | 4.1% | 2,062 | 2,049 | $521K | |
| 11981 | 3.9% | 2,145 | 2,123 | $487K | |
| S4993 | Contraceptive pills for birth control | 3.9% | 3,685 | 3,457 | $486K |
| 58300 | 3.2% | 4,271 | 2,121 | $398K | |
| S0190 | Mifepristone, oral, 200 mg | 3.0% | 6,189 | 6,124 | $378K |
| J7300 | Intrauterine copper contraceptive (paragard) | 1.8% | 235 | 232 | $226K |
40 more codes
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.7% | 2,910 | $210K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1.6% | 2,756 | $207K |
| 11976 | 1.4% | 2,832 | $172K | |
| G9920 | Screening performed and negative | 1.2% | 5,362 | $149K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 3,581 | $110K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 1,489 | $86K |
| 99152 | <1% | 1,874 | $84K | |
| A4267 | Contraceptive supply, condom, male, each | <1% | 7,965 | $81K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,323 | $68K |
| J7304 | Contraceptive supply, hormone containing patch, each | <1% | 27 | $66K |
| 58301 | <1% | 2,054 | $64K | |
| 76830 | Ultrasound, transvaginal | <1% | 816 | $50K |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 5,103 | $50K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,046 | $39K |
| 99201 | <1% | 493 | $24K | |
| S0191 | Misoprostol, oral, 200 mcg | <1% | 6,214 | $20K |
| G9919 | Screening performed and positive and provision of recommendations | <1% | 573 | $16K |
| 57454 | <1% | 236 | $13K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,045 | $13K |
| 01966 | <1% | 217 | $10K | |
| 87806 | <1% | 574 | $10K | |
| 59841 | <1% | 58 | $10K | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 754 | $9K |
| 11982 | <1% | 126 | $7K | |
| 81025 | <1% | 1,455 | $5K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 318 | $4K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 65 | $4K |
| 87799 | <1% | 112 | $3K | |
| 87481 | <1% | 126 | $2K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 101 | $2K |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | <1% | 473 | $2K |
| 99000 | <1% | 410 | $2K | |
| 87563 | <1% | 30 | $2K | |
| 83986 | <1% | 451 | $1K | |
| T1014 | Telehealth transmission, per minute, professional services bill separately | <1% | 537 | $768.77 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 134 | $672.26 |
| 81002 | <1% | 36 | $76.38 | |
| 85018 | <1% | 24 | $49.47 | |
| 87210 | <1% | 12 | $42.72 | |
| 86592 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.